Oak Harbor Wealth Partners’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Oak Harbor Wealth Partners's PFE Position: Q2 2026 in Review
Oak Harbor Wealth Partners increased its Pfizer (PFE) stake by 2.1% in Q2 2026, buying an estimated $36.7K and bringing the position to 68,388 shares worth $1.65M. The position accounts for 0.61% of the portfolio, ranked #47.
Oak Harbor Wealth Partners first reported a position in PFE in Q4 2021 and has held it in 19 quarters since. The position peaked at $4.15M in Q4 2021. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Oak Harbor Wealth Partners held 68,388 shares of Pfizer worth $1.65M as of Q2 2026.
- Oak Harbor Wealth Partners bought 1,402 Pfizer shares in Q2 2026, an estimated $36.7K.
- Pfizer made up 0.61% of Oak Harbor Wealth Partners's portfolio in Q2 2026, its #47 holding.
- Oak Harbor Wealth Partners first reported a position in Pfizer in Q4 2021 and has held it in 19 quarters since.
- Oak Harbor Wealth Partners's Pfizer position peaked at $4.15M in Q4 2021.
- 2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Oak Harbor Wealth Partners's 13F filing for Q2 2026, filed 6 Aug 2026.